Wide Ranks

CNTX

Context Therapeutics Inc.

1.50

Top Statistics
Market Cap 112 M Forward PE -4.84 Revenue Growth 0.00 %
Current Ratio 64.01 Trailing PE 0.0000 Earnings Growth 0.00 %
Profit Margins 0.00 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA -3.25 Enterprise / Revenue Price To Sales Trailing12 Months
Profitability
Profit Margins 0.00 % Operating Margins
Balance Sheet
Total Cash 101 M Total Cash Per Share 1.35 Total Debt
Total Debt To Equity Current Ratio 64.01 Book Value Per Share 0.7440
All Measures
Short Ratio 279.00 % Message Board Id finmb_408000800 Shares Short Prior Month 1 M
Return On Equity -0.2968 City Philadelphia Uuid 9370db4d-3fc8-33de-8dd0-aba14eeca611
Previous Close 1.47 First Trade Date Epoch Utc 1 B Book Value 0.7440
Beta 2.25 Volume 70644 Price To Book 2.02
Fifty Two Week Low 0.7900 Total Cash Per Share 1.35 Shares Short Previous Month Date 1 B
Target Median Price 9.00 Max Age 86400 Recommendation Mean 1.60
Sand P52 Week Change 0.3133 Target Mean Price 7.70 Net Income To Common -18566876
Short Percent Of Float 0.0154 Implied Shares Outstanding 74 M Trailing Peg Ratio None
Last Fiscal Year End 1 B Average Daily Volume10 Day 281460 Average Volume10days 281460
Total Cash 101 M Next Fiscal Year End 1 B Held Percent Insiders 0.0145
Trailing PE 0.0000 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 1.47 Target Low Price 4.50 Gmt Off Set Milliseconds -18000000
Fifty Day Average 1.96 Open 1.47 Free Cashflow -12332572
State PA Dividend Yield 0.00 % Return On Assets -0.1919
Time Zone Short Name EST Trailing Eps -0.8800 Day Low 1.47
Address1 2001 Market Street Shares Outstanding 74 M Price Hint 4
Target High Price 10.00 Website https://www.contexttherapeutics.com 52 Week Change 0.7647
Average Volume 281740 Forward Eps -0.2900 Recommendation Key buy
Compensation As Of Epoch Date 1 B Quick Ratio 6328.90 % Is_sp_500 False
Regular Market Day High 1.55 Profit Margins 0.00 % Fifty Two Week High 2.75
Day High 1.55 Shares Short 1 M Regular Market Open 1.47
Industry Key biotechnology Earnings Growth 0.00 % Revenue Growth 0.00 %
Shares Percent Shares Out 0.0137 Operating Cashflow -18404430 Currency USD
Time Zone Full Name America/New_York Market Cap 112 M Is_nasdaq_100 False
Zip 19103 Quote Type EQUITY Industry Biotechnology
Long Name Context Therapeutics Inc. Regular Market Day Low 1.47 Held Percent Institutions 0.7640
Current Price 1.50 Address2 Suite 3915 Unit #15 Enterprise To Ebitda -3.25
Financial Currency USD Current Ratio 64.01 Industry Disp Biotechnology
Number Of Analyst Opinions 5 Country United States Float Shares 39 M
Two Hundred Day Average 1.84 Enterprise Value 64 M Forward PE -4.84
Regular Market Volume 70644 Ebitda -20014956 Exchange NCM
Go to Yahoo Finance Go to Seeking Alpha 
Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors.

Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6.

The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy.

Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania.